Dynamic List Information
Dynamic List Data
Study Title
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) in t(11;14) Multiple Myeloma
Sponsor Name
Mayo Clinic
NCT Number
NCT06042725
IDE Number
G230104
CMS Approval Date
2024-02-22
Clinical Trial Link
Category
B